HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS (HIV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS (HIV) trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New HIV vaccine candidate enters early safety testing
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental HIV vaccine in 65 healthy adults to see if it is safe and triggers an immune response. The vaccine includes two HIV proteins (A244 and B.63521) plus an adjuvant (ALFQ) to boost the immune system. Participants received three shots over two months,…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE1 • Sponsor: U.S. Army Medical Research and Development Command • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:03 UTC
-
Vitamin D3 shows promise for immune support in HIV patients
Disease control CompletedThis study looked at whether taking vitamin D3 for 3 months can lower inflammation and boost immune cells in people with HIV who are already on antiretroviral therapy. Twenty adults with early-stage HIV took vitamin D3 supplements. Researchers measured changes in inflammation mar…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Universitas Sebelas Maret • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a website help end HIV in rural oklahoma?
Knowledge-focused CompletedThis completed study tested an online program designed to encourage HIV and syphilis testing, condom use, and PrEP uptake among young American Indian men and gay/bisexual men in rural Oklahoma. Researchers worked with community advisors to tailor health materials to local culture…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Northern Arizona University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC